|
|
Volumn 30, Issue 3, 2002, Pages 337-345
|
|
Nicardipine hydrochloride injectable phase IV open-label clinical trial: Study on the anti-hypertensive effect and safety of nicardipine for acute aortic dissection
a
|
|
Author keywords
Aortic dissection; Blood pressure; Hypertension; Nicardipine; Phase IV trial
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DILTIAZEM;
GLYCERYL TRINITRATE;
HYDRALAZINE;
NICARDIPINE;
NITROPRUSSIDE SODIUM;
PROPRANOLOL;
VERAPAMIL;
ANTIHYPERTENSIVE AGENT;
ADULT;
AGED;
ANTIHYPERTENSIVE ACTIVITY;
AORTA DISSECTION;
ARTICLE;
BLOOD PRESSURE MEASUREMENT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIASTOLIC BLOOD PRESSURE;
DISEASE CONTROL;
DRUG SAFETY;
FEMALE;
HUMAN;
HYPERTENSION;
MALE;
MEAN ARTERIAL PRESSURE;
MULTICENTER STUDY;
PHASE 4 CLINICAL TRIAL;
SIDE EFFECT;
SYSTOLIC BLOOD PRESSURE;
AORTA RUPTURE;
BLOOD PRESSURE;
PATHOPHYSIOLOGY;
TREATMENT OUTCOME;
ANTIHYPERTENSIVE AGENTS;
AORTIC RUPTURE;
BLOOD PRESSURE;
HUMANS;
NICARDIPINE;
TREATMENT OUTCOME;
|
|
EID: 0035988582
PISSN: 03000605
EISSN: None
Source Type: Journal
DOI: 10.1177/147323000203000318 Document Type: Article |
|
Times cited : (20)
|
|
References (16)
|
